Search by Drug Name or NDC
NDC 00641-6045-25 Lorazepam 4 mg/mL Details
Lorazepam 4 mg/mL
Lorazepam is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is LORAZEPAM.
Product Information
| NDC | 00641-6045 |
|---|---|
| Product ID | 0641-6045_2297cbcd-0026-412e-8186-1816b34c1d67 |
| Associated GPIs | 57100060002010 |
| GCN Sequence Number | 003756 |
| GCN Sequence Number Description | lorazepam VIAL 4 MG/ML INJECTION |
| HIC3 | H21 |
| HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
| GCN | 14141 |
| HICL Sequence Number | 004846 |
| HICL Sequence Number Description | LORAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | Lorazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lorazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/mL |
| Substance Name | LORAZEPAM |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA018140 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00641-6045-25 (00641604525)
| NDC Package Code | 0641-6045-25 |
|---|---|
| Billing NDC | 00641604525 |
| Package | 25 VIAL in 1 CARTON (0641-6045-25) / 1 mL in 1 VIAL (0641-6045-01) |
| Marketing Start Date | 1980-07-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |